These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16951150)

  • 1. Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer.
    Sunde JS; Donninger H; Wu K; Johnson ME; Pestell RG; Rose GS; Mok SC; Brady J; Bonome T; Birrer MJ
    Cancer Res; 2006 Sep; 66(17):8404-12. PubMed ID: 16951150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings.
    Grisaru D; Hauspy J; Prasad M; Albert M; Murphy KJ; Covens A; Macgregor PF; Rosen B
    Oncol Rep; 2007 Dec; 18(6):1347-56. PubMed ID: 17982616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
    Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
    Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordinately up-regulated genes in ovarian cancer.
    Hough CD; Cho KR; Zonderman AB; Schwartz DR; Morin PJ
    Cancer Res; 2001 May; 61(10):3869-76. PubMed ID: 11358798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance.
    Wamunyokoli FW; Bonome T; Lee JY; Feltmate CM; Welch WR; Radonovich M; Pise-Masison C; Brady J; Hao K; Berkowitz RS; Mok S; Birrer MJ
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):690-700. PubMed ID: 16467078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas.
    Birrer MJ; Johnson ME; Hao K; Wong KK; Park DC; Bell A; Welch WR; Berkowitz RS; Mok SC
    J Clin Oncol; 2007 Jun; 25(16):2281-7. PubMed ID: 17538174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer.
    Nanjundan M; Nakayama Y; Cheng KW; Lahad J; Liu J; Lu K; Kuo WL; Smith-McCune K; Fishman D; Gray JW; Mills GB
    Cancer Res; 2007 Apr; 67(7):3074-84. PubMed ID: 17409414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta.
    Jazag A; Ijichi H; Kanai F; Imamura T; Guleng B; Ohta M; Imamura J; Tanaka Y; Tateishi K; Ikenoue T; Kawakami T; Arakawa Y; Miyagishi M; Taira K; Kawabe T; Omata M
    Oncogene; 2005 Jan; 24(4):662-71. PubMed ID: 15592526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF beta-induced Smad signaling remains intact in primary human ovarian cancer cells.
    Dunfield LD; Dwyer EJ; Nachtigal MW
    Endocrinology; 2002 Apr; 143(4):1174-81. PubMed ID: 11897669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of suitable reference genes for gene expression studies of human serous ovarian cancer by real-time polymerase chain reaction.
    Li YL; Ye F; Hu Y; Lu WG; Xie X
    Anal Biochem; 2009 Nov; 394(1):110-6. PubMed ID: 19622337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform.
    Tsuda H; Birrer MJ; Ito YM; Ohashi Y; Lin M; Lee C; Wong WH; Rao PH; Lau CC; Berkowitz RS; Wong KK; Mok SC
    Cancer Genet Cytogenet; 2004 Dec; 155(2):97-107. PubMed ID: 15571795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer.
    Welsh JB; Zarrinkar PP; Sapinoso LM; Kern SG; Behling CA; Monk BJ; Lockhart DJ; Burger RA; Hampton GM
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1176-81. PubMed ID: 11158614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancer.
    Quinn MC; Filali-Mouhim A; Provencher DM; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2009 Jul; 48(7):648-61. PubMed ID: 19123201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis.
    Hinshelwood RA; Huschtscha LI; Melki J; Stirzaker C; Abdipranoto A; Vissel B; Ravasi T; Wells CA; Hume DA; Reddel RR; Clark SJ
    Cancer Res; 2007 Dec; 67(24):11517-27. PubMed ID: 18089780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.
    Wu YH; Chang TH; Huang YF; Huang HD; Chou CY
    Oncogene; 2014 Jun; 33(26):3432-40. PubMed ID: 23934190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of DACH1 promotes migration and invasion of colorectal cancer via activating TGF-β-mediated epithelial-mesenchymal transition.
    Wang P
    Biochem Biophys Res Commun; 2015 May; 460(2):314-9. PubMed ID: 25778865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.
    Fejzo MS; Dering J; Ginther C; Anderson L; Ramos L; Walsh C; Karlan B; Slamon DJ
    Genes Chromosomes Cancer; 2008 Oct; 47(10):873-83. PubMed ID: 18615678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor beta.
    Havrilesky LJ; Hurteau JA; Whitaker RS; Elbendary A; Wu S; Rodriguez GC; Bast RC; Berchuck A
    Cancer Res; 1995 Feb; 55(4):944-8. PubMed ID: 7531618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
    Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
    Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.